Testing effectiveness (Phase 2)Ended earlyNCT04373044
What this trial is testing
Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19
Who this might be right for
Symptomatic COVID-19 Infection Laboratory-Confirmed
University of Southern California 6